The Novel Alpha-2 Adrenoceptor Inhibitor Beditin Reduces Cytotoxicity and Huntingtin Aggregates in Cell Models of Huntington’s Disease

Huntington’s disease (HD) is a monogenetic neurodegenerative disorder characterized by the accumulation of polyglutamine-expanded huntingtin (mHTT). There is currently no cure, and therefore disease-slowing remedies are sought to alleviate symptoms of the multifaceted disorder. Encouraging findings...

Full description

Bibliographic Details
Published in:	Pharmaceuticals
Main Authors:	Elisabeth Singer, Lilit Hunanyan, Magda M. Melkonyan, Jonasz J. Weber, Lusine Danielyan, Huu Phuc Nguyen
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Subjects:	Huntington’s disease huntingtin neurodegeneration alpha-2 adrenoceptor beditin autophagy
Online Access:	https://www.mdpi.com/1424-8247/14/3/257

Similar Items

Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models
by: Rona K. Graham, et al.
Published: (2006-02-01)

Altered huntingtin−chromatin interactions predict transcriptional and epigenetic changes in Huntington's disease
by: Jocelynn R. Pearl, et al.
Published: (2025-05-01)

Bypassing mitochondrial defects rescues Huntington's phenotypes in Drosophila
by: Susanna Campesan, et al.
Published: (2023-09-01)

Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease
by: Stefan Bartl, et al.
Published: (2024-01-01)

HAP40 protein levels are huntingtin-dependent and decrease in Huntington disease
by: Bin Huang, et al.
Published: (2021-10-01)

Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification
by: Rachel J. Harding, et al.
Published: (2025-04-01)

SUMO-modifying Huntington’s disease
by: Ericks S. Soares, et al.
Published: (2022-06-01)

Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?
by: José Bono-Yagüe, et al.
Published: (2020-07-01)

Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington’s Disease Models
by: Letizia Pruccoli, et al.
Published: (2021-10-01)

Navigating the neuronal recycling bin: Another look at huntingtin in coordinating autophagy
by: Thomas J. Krzystek, et al.
Published: (2025-12-01)

Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington’s disease cases
by: Shireen Salem, et al.
Published: (2024-08-01)

The N17 domain of huntingtin as a multifaceted player in Huntington’s disease
by: Hyunju Cho
Published: (2025-01-01)

Synaptic and functional alterations in the development of mutant huntingtin expressing hiPSC‐derived neurons
by: Margarita C. Dinamarca, et al.
Published: (2022-07-01)

Huntingtin plays an essential role in the adult hippocampus
by: Jessica C. Barron, et al.
Published: (2025-03-01)

Corrigendum: The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function
by: Wojciech J. Szlachcic, et al.
Published: (2017-09-01)

Oleuropein enhances proteasomal activity and reduces mutant huntingtin-induced cytotoxicity
by: Zih-Ning Huang, et al.
Published: (2024-09-01)

Small molecule modulation of p75NTR engages the autophagy-lysosomal pathway and reduces huntingtin aggregates in cellular and mouse models of Huntington's disease
by: Danielle A. Simmons, et al.
Published: (2025-03-01)

mTOR inhibition in Q175 Huntington’s disease model mice facilitates neuronal autophagy and mutant huntingtin clearance
by: Philip Stavrides, et al.
Published: (2025-05-01)

Zika virus impairs non-homologous end joining and exacerbates DNA damage in neural progenitors derived from Huntington’s disease iPSCs via mutant huntingtin-elicited Ku70/Ku80 complex disruption
by: Feng-Lan Chiu, et al.
Published: (2025-08-01)

Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington’s disease mice
by: Nicholas S. Caron, et al.
Published: (2024-10-01)

The contribution of glial cells to Huntington's disease pathogenesis
by: Daniel K. Wilton, et al.
Published: (2020-09-01)

Optimization of trans-Splicing for Huntington's Disease RNA Therapy
by: Hansjörg Rindt, et al.
Published: (2017-10-01)

Ubiquitin-modifying enzymes in Huntington’s disease
by: Karen A. Sap, et al.
Published: (2023-02-01)

UBL3 Interacts with PolyQ-Expanded Huntingtin Fragments and Modifies Their Intracellular Sorting
by: Soho Oyama, et al.
Published: (2024-10-01)

Mutant Huntingtin Forms in Vivo Complexes with Distinct Context-Dependent Conformations of the Polyglutamine Segment
by: Francesca Persichetti, et al.
Published: (1999-10-01)

Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights
by: Chih‐Wei Tung, et al.
Published: (2025-04-01)

Evaluation of an Antisense Oligonucleotide Targeting CAG Repeats: A Patient-Customized Therapy Study for Huntington’s Disease
by: Sergio Adrian Ocampo-Ortega, et al.
Published: (2024-12-01)

Gene Silencing Therapies for Huntington’s Disease
by: Chunlan Hao, et al.
Published: (2025-05-01)

Molecular Pathophysiological Mechanisms in Huntington’s Disease
by: Anamaria Jurcau
Published: (2022-06-01)

Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane
by: Aisha M. Swaih, et al.
Published: (2022-09-01)

Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease
by: Francesco D’Egidio, et al.
Published: (2023-02-01)

Juvenile Huntington's disease: a clinical case from a pediatric's practice
by: Emilia E. Alieva, et al.
Published: (2023-11-01)

Upregulation of the ESCRT pathway and multivesicular bodies accelerates degradation of proteins associated with neurodegeneration
by: Ron Benyair, et al.
Published: (2023-12-01)

Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
by: Frauke van Bebber, et al.
Published: (2010-09-01)

Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington’s disease
by: Magdalena eCzeredys, et al.
Published: (2013-11-01)

Immunohistochemical Distribution and Neurochemical Characterization of Huntingtin-Associated Protein 1 Immunoreactive Neurons in the Adult Mouse Lingual Ganglia
by: Md Nabiul Islam, et al.
Published: (2023-02-01)

Phagocytic glia are obligatory intermediates in transmission of mutant huntingtin aggregates across neuronal synapses
by: Kirby M Donnelly, et al.
Published: (2020-05-01)

Full-length huntingtin is palmitoylated at multiple sites and post-translationally myristoylated following caspase-cleavage
by: Fanny L. Lemarié, et al.
Published: (2023-01-01)

Altering cortical input unmasks synaptic phenotypes in the YAC128 cortico-striatal co-culture model of Huntington disease
by: Mandi E. Schmidt, et al.
Published: (2018-06-01)

Exploring the role of ferroptosis pathways in Huntington's disease: Insight of pathophysiology to emerging treatment
by: Mohd Haris Jamal, et al.
Published: (2025-06-01)